Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 223 entries
View as:

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Phase: N/A Priority: Normal
NCT ID: NCT00648999 Org: User:
Start: 11/30/03 End: 12/31/06 Due: 12/31/07

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Phase: N/A Priority: Normal
NCT ID: NCT01221298 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Surveillance of Humira Injection in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT01083121 Org: User:
Start: 04/30/07 End: 06/30/12 Due: 06/30/13

Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01123876 Org: User:
Start: 03/31/10 End: 01/31/15 Due: 01/31/16

Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01559038 Org: User:
Start: 02/16/12 End: 11/19/19 Due: 11/19/20

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Phase: N/A Priority: Normal
NCT ID: NCT01472003 Org: User:
Start: 10/31/11 End: 12/31/12 Due: 12/31/13

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

Phase: N/A Priority: Normal
NCT ID: NCT00497146 Org: User:
Start: 02/29/08 End: 03/31/12 Due: 03/31/13

A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission

Phase: N/A Priority: Normal
NCT ID: NCT00808509 Org: User:
Start: 01/31/09 End: 09/30/12 Due: 09/30/13

Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

Phase: N/A Priority: Normal
NCT ID: NCT01083680 Org: User:
Start: 05/31/07 End: 12/31/15 Due: 12/31/16

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00640419 Org: User:
Start: 03/31/08 End: 07/31/08 Due: 07/31/09

Clinical Practice of Inhalation Anesthesia With Sevoflurane in China

Phase: N/A Priority: Normal
NCT ID: NCT01715857 Org: User:
Start: 07/31/12 End: 07/31/13 Due: 07/31/14

A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Phase: N/A Priority: Normal
NCT ID: NCT01074008 Org: User:
Start: 03/31/10 End: 01/31/12 Due: 01/31/13

Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

Phase: N/A Priority: Normal
NCT ID: NCT01076192 Org: User:
Start: 02/28/10 End: 09/30/14 Due: 09/30/15

A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01579279 Org: User:
Start: 04/30/12 End: 05/31/12 Due: 05/31/13

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Phase: N/A Priority: Normal
NCT ID: NCT00141518 Org: User:
Start: 03/31/06 End: 04/30/11 Due: 04/30/12

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00920764 Org: User:
Start: 06/30/09 End: 05/31/10 Due: 05/31/11

Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01316224 Org: User:
Start: 04/30/11 End: 04/30/14 Due: 04/30/15

A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Phase: N/A Priority: Normal
NCT ID: NCT01458535 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01668511 Org: User:
Start: 09/30/12 End: 10/31/13 Due: 10/31/14

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01704755 Org: User:
Start: 10/31/12 End: 09/30/14 Due: 09/30/15

A Study of ABT-414 in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01741727 Org: User:
Start: 10/31/12 End: 11/30/15 Due: 11/30/16

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01265823 Org: User:
Start: 10/31/10 End: 02/29/12 Due: 02/28/13

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01009073 Org: User:
Start: 10/31/09 End: 06/30/13 Due: 06/30/14

Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT01428115 Org: User:
Start: 12/31/11 End: 10/31/13 Due: 10/31/14

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01690195 Org: User:
Start: 09/30/12 End: 02/28/14 Due: 02/28/15